5-溴-2-甲氧基苯酚 | 37942-01-1

• 物质功能分类: 化学试剂 - 有机试剂
• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: 5-溴-2-甲氧基苯酚
• 中文别名: 3-羟基-4-甲氧基溴苯；5-溴愈创木酚；5-溴-2-甲氧基-苯酚(5-溴愈创木酚)和愈创木酚碳酸酯；5-溴-2-甲氧基-苯酚
• 英文名称: 5-bromo-2-methoxyphenol
• 英文别名: 5-bromoguaiacol；2-methoxy-5-bromophenol；3-hydroxy-4-methoxybromobenzene；1-Methoxy-2-hydroxy-4-bromo-benzene
• CAS: 37942-01-1
• 化学式: C₇H₇BrO₂
• 分子量: 203.035
• InChiKey: OLSJHVZRUFFIPL-UHFFFAOYSA-N

物化性质

• 熔点：
  64-70
• 沸点：
  150 °C / 20mmHg
• 密度：
  1.585±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R20/21/22
• 海关编码：
  2909500000
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  Store Cold

SDS

5-Bromo-2-methoxyphenol Revision number: 1
SAFETY DATA SHEET

---

Section 1. BASE INFORMATION
Product name: 5-Bromo-2-methoxyphenol

Revision number: 1

---

Section 2. HAZARDS IDENTIFICATION
Classification of the GHS
PHYSICAL HAZARDS Not classified
HEALTH HAZARDS
Category 2
Skin corrosion/irritation
Serious eye damage/eye irritation Category 2A
Not classified
ENVIRONMENTAL HAZARDS
GHS label elements
Pictograms or hazard symbols
Signal word Warning
Hazard statement Causes skin irritation
Causes serious eye irritation
Precautionary statements
[Prevention] Wash hands thoroughly after handling.
Wear protective gloves/eye protection/face protection.
[Response] IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses,
if present and easy to do. Continue rinsing.
If eye irritation persists: Get medical advice/attention.
IF ON SKIN: Gently wash with plenty of soap and water.
If skin irritation occurs: Get medical advice/attention.
Take off contaminated clothing and wash before reuse.

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substance/mixture: Substance
Component(s): 5-Bromo-2-methoxyphenol
Percent: >98.0%(GC)(T)
CAS Number: 37942-01-1
Synonyms: 4-Bromo-2-hydroxyanisole
Chemical Formula: C7H7BrO2

---

Section 4. FIRST AID MEASURES
Inhalation: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
Get medical advice/attention if you feel unwell.
5-Bromo-2-methoxyphenol

---

Section 4. FIRST AID MEASURES
Skin contact: Remove/Take off immediately all contaminated clothing. Gently wash with plenty of
soap and water. If skin irritation or rash occurs: Get medical advice/attention.
Eye contact: Rinse cautiously with water for several minutes. Remove contact lenses, if present
and easy to do. Continue rinsing. If eye irritation persists: Get medical
advice/attention.
Ingestion: Get medical advice/attention if you feel unwell. Rinse mouth.
A rescuer should wear personal protective equipment, such as rubber gloves and air-
Protection of first-aiders:
tight goggles.

---

Section 5. FIRE-FIGHTING MEASURES
Suitable extinguishing Dry chemical, foam, water spray, carbon dioxide.
media:
Specific hazards: Take care as it may decompose upon combustion or in high temperatures to
generate poisonous fume.
Specific methods: Fire-extinguishing work is done from the windward and the suitable fire-extinguishing
method according to the surrounding situation is used. Uninvolved persons should
evacuate to a safe place. In case of fire in the surroundings: Remove movable
containers if safe to do so.
Special protective When extinguishing fire, be sure to wear personal protective equipment.
equipment for firefighters:

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, Use personal protective equipment. Keep people away from and upwind of spill/leak.
protective equipment and Entry to non-involved personnel should be controlled around the leakage area by
emergency procedures: roping off, etc.
Environmental precautions: Prevent product from entering drains.
Methods and materials for Sweep dust to collect it into an airtight container, taking care not to disperse it.
containment and cleaning Adhered or collected material should be promptly disposed of, in accordance with
up: appropriate laws and regulations.

---

Section 7. HANDLING AND STORAGE
Handling
Technical measures: Handling is performed in a well ventilated place. Wear suitable protective equipment.
Prevent dispersion of dust. Wash hands and face thoroughly after handling.
Use a local exhaust if dust or aerosol will be generated.
Advice on safe handling: Avoid contact with skin, eyes and clothing.
Storage
Keep container tightly closed. Store in a cool and dark place.
Storage conditions:
Store away from incompatible materials such as oxidizing agents.
Packaging material: Law is followed.

---

Section 8. EXPOSURE CONTROLS / PERSONAL PROTECTION
Engineering controls: Install a closed system or local exhaust as possible so that workers should not be
exposed directly. Also install safety shower and eye bath.
Personal protective equipment
Respiratory protection: Dust respirator. Follow local and national regulations.
Hand protection: Protective gloves.
Eye protection: Safety glasses. A face-shield, if the situation requires.
Skin and body protection: Protective clothing. Protective boots, if the situation requires.

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Physical state (20°C): Solid
Form: crystal - powder
Color: White - Very pale yellow
Odor: No data available
pH: No data available
5-Bromo-2-methoxyphenol

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Melting point/freezing point:65 °C
Boiling Point/Range: 150 °C/2.7kPa
Flash Point: No data available
Explosive limits
Lower: No data available
No data available
Upper:
Density: No data available
No data available
Solubility:

---

Section 10. STABILITY AND REACTIVITY
Stability: Stable under proper conditions.
Reactivity: No special reactivity has been reported.
Incompartible materials: oxidizing agents
Hazardous Decomposition Carbon monoxide, Carbon dioxide, Hydrogen bromide
Products:

---

Section 11. TOXICOLOGICAL INFORMATION
Acute Toxicity: No data available
Skin corrosion/irritation: No data available
Serious eye No data available
damage/irritation:
Germ cell mutagenicity: No data available
Carcinogenicity:
IARC = No data available
No data available
NTP =
Reproductive toxicity: No data available

---

Section 12. ECOLOGICAL INFORMATION
Ecotoxicity:
Fish: No data available
Crustacea: No data available
Algae: No data available
Persistence / degradability: No data available
Bioaccumulative No data available
potential(BCF):
Mobillity in soil
log Pow: No data available
Soil adsorption (Koc): No data available
Henry's Law No data available
constant(PaM3/mol):

---

Section 13. DISPOSAL CONSIDERATIONS
Recycle to process, if possible. Consult your local regional authorities. You may be able to dissolve or mix material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber system.
Observe all federal, state and local regulations when disposing of the substance.

---

Section 14. TRANSPORT INFORMATION
Hazards Class: Does not correspond to the classification standard of the United Nations
UN-No: Not Listed

---

Section 15. REGULATORY INFORMATION
Safe management ordinance of dangerous chemical product (State Council announces on January 26,
2002): Safe use and production, the storage of a dangerous chemical, transport, loading and unloading were
prescribed.
5-Bromo-2-methoxyphenol

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

用途：农药和医药产品中间体

反应信息

• 作为反应物：
  描述：

  5-溴-2-甲氧基苯酚 在 (1S,4S)-2,5-diphenylbicyclo[2.2.2]octa-2,5-diene 、 正丁基锂 、 chlorobis(ethylene)rhodium(I) dimer 、 potassium carbonate 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 、 正己烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 32.5h， 生成 阿普斯特
  参考文献：
  名称：

  手性二烯配体的铑催化剂不对称合成β-芳基β-亚氨基砜：Apremilast的合成

  摘要：

  手性铑（I）-二烯催化剂可在温和的反应条件下一步合成β-芳基β-亚氨基砜。通过选择手性二烯配体L1a或L2，可以以高的立体选择性接近手性β-芳基β-亚氨基砜靶的每个对映体。证明反应的范围，包括合成一个N保护的手性β-氨基β-苯基砜，并以有效合成富含杂原子的活性药物成分apremilast达到顶点。

  DOI：

  10.1021/acs.orglett.9b01513
• 作为产物：
  描述：

  木榴油 在 吡啶 、 甲醇 、 N-溴代丁二酰亚胺(NBS) 、 碳酸氢钠 作用下， 以 乙腈 为溶剂， 反应 22.0h， 生成 5-溴-2-甲氧基苯酚
  参考文献：
  名称：

  格氏试剂铜催化炔丙基取代合成对映体富集形式的 TNF 抑制剂、氟比洛芬和 i-Pr 类似物

  摘要：

  由 TMSC CCH(OH)CH 2 CH 2 OTBDPS 衍生的磷酸二乙酯与 3- c -C 5 H 9 -4-MeOC 6 H 3 MgBr在铜催化下发生取代反应，然后进行多次转化，得到肿瘤坏死因子抑制剂具有Ph-乙炔部分。该抑制剂也由磷酸苯乙炔PhC CCH(OP(O)(OEt) 2 )CH 2 CH 2 OTBDPS合成。此外，衍生自 TMSC CCH(OH)CH 3和 TMSC CCH(OH)- i -Pr 的磷酸盐被 3-F-4-PhC 6 H取代3 MgBr 得到相应的替代产物，分别转化为氟比洛芬及其i- Pr 类似物。这些合成中的铜催化取代以区域选择性和立体选择性方式进行。

  DOI：

  10.1039/d1ob01944a
• 作为试剂：
  描述：

  5-溴-2-甲氧基苯甲醛 、 间氯过氧苯甲酸 在 5-溴-2-甲氧基苯酚 、 ice 、 Disodium;sulfite 、 乙醚 、 sodium hydroxide 、 magnesium sulfate 作用下， 以 二氯甲烷 为溶剂， 反应 74.0h， 以to afford intermediate 5-bromo-2-methoxy-phenol (43.5 g, 90%)的产率得到5-溴-2-甲氧基苯酚
  参考文献：
  名称：

  THERAPEUTIC PIPERAZINES

  摘要：

  本发明涉及一种I式化合物：其中R1，Y，A，n，R4和Z具有以下任一数值，以及这些化合物的盐，包含这些化合物的组合物和包括这些化合物的治疗方法。这些化合物是PDE4功能的抑制剂，可用于改善动物（尤其是人类）的认知功能和/或治疗认知障碍或损伤、中枢和外周神经系统的创伤和/或缺血性损伤以及/或精神障碍。

  公开号：

  US20150087645A1

文献信息

• Substituted dibenzo[ c,h ]cinnolines: topoisomerase I-targeting anticancer agents
  作者：Younong Yu、Sudhir K Singh、Angela Liu、Tsai-Kun Li、Leroy F Liu、Edmond J LaVoie

  DOI：10.1016/s0968-0896(02)00604-1

  日期：2003.4

  9-methylenedioxybenzo[i]phenanthridine is one of the more potent benzo[i]phenanthridine derivatives in regard to topoisomerase I-targeting activity and cytotoxicity. The structure-activity relationship observed with these substituted dibenzo[c,h]cinnolines parallels that observed for benzo[i]phenanthridine derivatives. Compared to similarly substituted benzo[i]phenanthridines, the dibenzo[c,h]cinnoline analogues

  合成了几种取代的二苯并[c，h]肉桂啉，并评估了其靶向拓扑异构酶I的潜力以及相对的细胞毒性活性。选择的苯并[i]菲啶能够稳定由拓扑异构酶I和DNA形成的可裂解复合物。开始这项研究以检查本质上是苯并[i]菲啶的氮杂类似物的二苯并[c，h] cinnolines是否具有相似的药理特性。就靶向拓扑异构酶I的活性和细胞毒性而言，2，3-二甲氧基-8，9-亚甲基二氧基苯并[i]菲啶是更有效的苯并[i]菲啶衍生物之一。用这些取代的二苯并[c，h] cinnolines观察到的结构活性关系与苯并[i]菲啶衍生物观察到的相似。与类似取代的苯并[i]菲啶相比，二苯并[c，h] cinnoline类似物表现出更强的拓扑异构酶I靶向活性和细胞毒性。在评估2,3-二甲氧基-8,9-亚甲基二氧基二苯并[c，h] cinnoline和2,3-二甲氧基-8,9-亚甲基二氧基苯并[i]菲啶在人淋巴母细胞瘤中的细胞毒性时获
• [EN] PHOSPHODIESTERASE INHIBITORS<br/>[FR] INHIBITEURS DE PHOSPHODIESTÉRASE
  申请人：US GOV HEALTH & HUMAN SERV

  公开号：WO2009089027A1

  公开（公告）日：2009-07-16

  The invention relates to compounds of formula I useful for inhibiting phosphodiesterase-4.

  这项发明涉及到公式I的化合物，用于抑制磷酸二酯酶-4。
• 有害生物防除方法
  申请人：住友化学株式会社

  公开号：JP2021152084A

  公开（公告）日：2021-09-30

  【課題】有害生物の防除方法を提供すること。【解決手段】式（Ｉ）〔式（Ｉ）中、ＱはＱ１で示される基（●はベンゼン環との結合部位を表す）等を表し、Ｅは、Ｃ１−Ｃ６鎖式炭化水素基等を表し、Ｒ1は、Ｃ１−Ｃ３鎖式炭化水素基等を表し、ｎは、０、１、２又は３を表し、ｎが２又は３である場合、複数のＲ2は同一又は異なっていてもよく、Ｒ2は、Ｃ１−Ｃ３鎖式炭化水素基等を表す。〕で示される化合物、又はそのＮオキシド若しくはそれらの塩は有害生物を防除することができる。【選択図】なし

  提供有害生物防治方法。在式（Ｉ）中，Ｑ代表基（●表示与苯环结合部位），Ｅ代表Ｃ₁−Ｃ₆链状烃基，Ｒ₁代表Ｃ₁−Ｃ₃链状烃基，ｎ代表０、１、２或３，若ｎ为２或３，则多个Ｒ₂可相同或不同，Ｒ₂代表Ｃ₁−Ｃ₃链状烃基。所述化合物、其Ｎ氧化物或盐可防治有害生物。【选择图】无
• NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION
  申请人：Buckman Brad

  公开号：US20110152246A1

  公开（公告）日：2011-06-23

  The embodiments provide compounds of the general Formulae I, II, III, IV, or V as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.

  实施例提供了一般式I、II、III、IV或V的化合物，以及包括药物组合物在内的组合物，其中包括一种主体化合物。实施例还提供了治疗方法，包括治疗丙型肝炎病毒感染的方法和治疗肝纤维化的方法，这些方法通常涉及向需要的个体施用一种主体化合物或组合物的有效量。
• [EN] FUSED TRICYCLIC COMPOUNDS AND USES THEREOF IN MEDICINE<br/>[FR] COMPOSÉS TRYCICLIQUES CONDENSÉS ET UTILISATIONS CORRESPONDANTES EN MÉDECINE
  申请人：SUNSHINE LAKE PHARMA CO LTD

  公开号：WO2018219356A1

  公开（公告）日：2018-12-06

  The present invention relates to a fused tricyclic compound and use thereof as a medicament, in particular as a medicament for the treatment and/or prevention of hepatitis B. Specifically, the invention relates to a compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, wherein each variate is as defined in specification. The invention also relates to the use of the compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof as a medicament, especially as a medicament for the treatment and/or prevention of hepatitis B.

  本发明涉及一种融合三环化合物及其作为药物的用途，特别是作为治疗和/或预防乙型肝炎的药物。具体地，本发明涉及具有化学式（I）或其立体异构体、互变异构体、N-氧化物、溶剂合物、代谢物、药学上可接受的盐或其前药的化合物，其中每个变量如规范中所定义。本发明还涉及将具有化学式（I）或其立体异构体、互变异构体、N-氧化物、溶剂合物、代谢物、药学上可接受的盐或其前药用作药物，特别是作为治疗和/或预防乙型肝炎的药物。

表征谱图